Submitted by Anonymous (not verified) on 28 January 2025 - 10:53
Human medicines European public assessment report (EPAR): Trajenta, linagliptin, Date of authorisation: 23/08/2011, Revision: 22, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Trajenta, linagliptin, Date of authorisation: 23/08/2011, Revision: 22, Status: Authorised